Toward operative in vivo fluorescence imaging of the c‐ M et proto‐oncogene for personalization of therapy in ovarian cancer

Biomarker‐based selection for targeted therapy has been a key criterion for the successful application of targeted therapies. This work demonstrates the utility of an in‐house developed optical imaging system for detecting the expression of the c‐Met oncogene in submillimeter ovarian cancer deposits...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 2015-01, Vol.121 (2), p.202-213
Main Authors: Liu, Shujuan, Zheng, Yong, Volpi, Davide, El‐Kasti, Muna, Klotz, Daniel, Tullis, Iain, Henricks, Andrea, Campo, Leticia, Myers, Kevin, Laios, Alex, Thomas, Peter, Ng, Tony, Dhar, Sunanda, Becker, Christian, Vojnovic, Borivoj, Ahmed, Ahmed Ashour
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Biomarker‐based selection for targeted therapy has been a key criterion for the successful application of targeted therapies. This work demonstrates the utility of an in‐house developed optical imaging system for detecting the expression of the c‐Met oncogene in submillimeter ovarian cancer deposits.
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.29029